Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 10Hemoptysis 3Pneumonia 2Lung Diseases 2Carcinoma, Non-Small-Cell Lung 2Tuberculosis 1Small Cell Lung Carcinoma 1Pulmonary Fibrosis 1Pulmonary Disease, Chronic Obstructive 1Neoplasms 1Lung Diseases, Obstructive 1Lung Diseases, Interstitial 1Laryngeal Neoplasms 1Disease 1Bronchitis 1Bronchiectasis 1

Interventions

atezolizumab 5durvalumab 4Drug Therapy 4Carboplatin 4Psychiatric Rehabilitation 3Immunotherapy 3Topotecan 2Specimen Handling 2Radiotherapy 2Polymerase Chain Reaction 2PM 01183 2Observation 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Ifosfamide 2Etoposide 2Cisplatin 2Biopsy 2trastuzumab deruxtecan 1nedaplatin 1X-Ray Therapy 1Watchful Waiting 1Vinorelbine 1Tomography, Optical Coherence 1Tissue Banks 1Therapeutics 1Radiation, Ionizing 1Phlebotomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Small Cell Lung Carcinoma × Bronchoscopy × Clear all
NCT00899457 2014-06-24

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

Vanderbilt-Ingram Cancer Center

Completed
37 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡